Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 1 examiners • 0 of 3 (0%) have an AI response strategy ready
Keto Innovations LLC currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. All 3 of these actions are assigned to 1 distinct examiner working within 1 distinct art unit. This concentration of matters under a single examiner suggests that the portfolio's prosecution success is heavily dependent on a single individual's perspective and interpretation of the law.
The busiest examiner, NEAGU, IRINA, is responsible for all 3 pending office actions. This means that the practitioner has the opportunity to build a consistent rapport and understanding with NEAGU, IRINA across the entire pending portfolio. However, it also means that any systemic disagreement with the examiner's approach will affect all 3 pending office actions simultaneously. The legal team should look for common themes in the rejections across the 3 pending office actions.
The use of 1 distinct art unit for all 3 pending office actions ensures a uniform application of technical standards and procedural rules. Practitioners should develop a cohesive strategy that addresses the concerns of the 1 distinct examiner while maintaining consistency across the portfolio. Successfully managing the relationship with NEAGU, IRINA is the primary path to advancing the 3 pending office actions. This focused structure allows for an efficient use of legal resources by addressing multiple matters through a single point of contact.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEAGU, IRINA | 3 | 46.8% | +57.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18319334 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | NEAGU, IRINA | 141d overdue |
| 18225093 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | NEAGU, IRINA | 89d overdue |
| 18157788 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | NEAGU, IRINA | — |
| Art Unit | Apps |
|---|---|
| 1629 | 3 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18225093 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | NEAGU, IRINA | 1629 | §103§112DP | Final Rejection | 89d overdue | Pending | Jul 21, 2023 |
| 18319334 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | NEAGU, IRINA | 1629 | §103§112DP | Final Rejection | 141d overdue | Pending | May 17, 2023 |
| 18157788 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR THERAPEUTIC AND PERFORMANCE SUPPLEMENTATION | NEAGU, IRINA | 1629 | §102§103§112DP | Final Rejection | — | Pending | Jan 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial